Serum High Sensitivity C-Reactive Protein and Uric Acid as Biomarkers of Left Ventricular Hypertrophy in Hypertensive Patients in Makurdi, Nigeria

Abstract

Hypertension is a major cause of mortality worldwide and a major global health challenge. Hypertensive heart diseases 
including left ventricular hypertrophy are chronic complications of hypertension and are associated with worsening prognosis 
and progression to poor outcomes in affected patients. It is imperative that left ventricular hypertrophy is detected early to 
forestall these untoward outcomes. Current diagnostic tools available often detect structural and functional defects, however
markers like hsCRP and uric acid are expressed much earlier before structural defects begin and may help to delay and possibly 
prevent hypertensive heart diseases when detected early. A total of 211 hypertensive patients with and those without left 
ventricular hypertrophy were recruited, hsCRP and uric acid were measured and compared between the two groups. Both 
markers were significantly elevated in hypertensive patients with left ventricular hypertrophy compared to those without left
ventricular hypertrophy. hsCRP and uric acid also showed high sensitivity (76.1% vs 77.9%) and diagnostic efficiency (70.1% 
vs 71.1%) when used individually and when both are combined (77.6% and 74.4%), in detecting left ventricular hypertrophy 
in hypertensive patients. Thus, these markers may be employed in monitoring hypertensive patients to improve their quality 
of life and treatment outcomes.